Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure

Circulation

Volumn 102, Issue 18, 2000, Pages 2210-2213

  Malendowicz, Slawomir L ^a   Ennezat, Pierre V ^a   Testa, Marco ^a   Murray, Laura ^a   Sonnenblick, Edmund H ^a   Evans, Todd ^a   Le Jemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensins; Heart failure; Muscle, skeletal; Receptors

Indexed keywords

ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOSINOPRIL; FUROSEMIDE; LISINOPRIL; NITRATE; RECEPTOR SUBTYPE; RNA; VALSARTAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

EID: 0034739479     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.18.2210     Document Type: Article

References (26)

1. The emerging concept of vascular remodeling
2. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
3. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure
4. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure
5. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure: A double-blind, placebo-controlled trial
6. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
7. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
8. Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure: Vasodilator Heart Failure Trial (V-HeFT) study group
9. Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure
10. Radioiodinated CGP 42112A: A novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors
11. AT1 and AT2 angiotensin receptor gene expression in human heart failure
12. The sequence and genomic organization of the human type 2 angiotensin II receptor
13. Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis
14. The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species
15. cDNA sequences for human yon Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms
16. Changes in expression of angiotensin receptor subtypes in the rat aorta-during development
17. Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography
18. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle
19. The angiotensin AT2-receptor mediatcs inhibition of cell proliferation in coronary endothelial cells
20. Bovine aortic endothelial cells contain an angiotensin-(1-7)receptor
21. Angiotensin II binding activity in cultured porcine arterial endothelial cells
22. Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat
23. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
24. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation
25. Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization
26. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial: The Losartan Heart Failure Survival Study ELITE II